Skip to content

Author

Franziska Hopfner

We have 3 of 108 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Toward the prevention of clinically manifest Parkinson's disease.

The central purpose of this article is to define a desired destination around which the field can organize scientific innovation, including validated biological staging, risk stratification, longitudinal biomarker trajectories, trial enrichment, preventive endpoints, regulatory qualification, scalable implementation, a...

Günther U. Höglinger, Franziska Hopfner · 0 citations
Aug 2026

[Multiple system atrophy].

Ongoing research aims to establish sensitive biomarkers, identify prodromal disease stages, and develop targeted interventions addressing key pathophysiological mechanisms such as α-synuclein aggregation and neuroinflammation.

I. Wilkens, Sabrina Katzdobler, A. Bernhardt et al. · 1 citation
Review Open access Jul 2026

Multiple system atrophy: cure and care.

Bridging advances in pathophysiology with patient-centred care will be essential for improving outcomes in MSA, and advances in fluid biomarkers and multimodal imaging are expected to facilitate earlier detection, improve diagnostic accuracy, and provide more robust tools for monitoring disease progression.

J. Buonocore, Bianca Calió, Fabian Leys et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.